AVNS
Avanos Medical Inc
NYSE: AVNS · HEALTHCARE · MEDICAL DEVICES
$24.64
-0.06% today
Updated 2026-04-30
Market cap
$1.15B
P/E ratio
—
P/S ratio
1.64x
EPS (TTM)
$-1.57
Dividend yield
—
52W range
$9 – $25
Volume
1.4M
Avanos Medical Inc (AVNS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-10.40%
Operating margin
1.99%
ROE
-9.08%
ROA
0.87%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | $1.66B | $142.40M | 35.59% | 12.52% | 8.58% |
| 2012 | $1.68B | $152.60M | 35.78% | 13.45% | 9.06% |
| 2013 | $1.68B | $154.60M | 36.49% | 13.29% | 9.22% |
| 2014 | $1.67B | $27.10M | 36.40% | 18.63% | 1.62% |
| 2015 | $1.57B | $-426.30M | 33.77% | 9.83% | -27.08% |
| 2016 | $566.20M | $39.80M | 52.49% | -12.26% | 7.03% |
| 2017 | $611.60M | $79.30M | 55.09% | -2.62% | 12.97% |
| 2018 | $652.30M | $57.50M | 59.93% | 5.35% | 8.81% |
| 2019 | $697.60M | $-45.90M | 57.65% | -0.77% | -6.58% |
| 2020 | $714.80M | $-27.20M | 54.64% | 9.92% | -3.81% |
| 2021 | $744.60M | $6.30M | 51.02% | 11.66% | 0.85% |
| 2022 | $684.10M | $50.50M | 57.62% | 6.12% | 7.38% |
| 2023 | $673.30M | $-61.80M | 56.39% | 9.65% | -9.18% |
| 2024 | $687.80M | $-392.10M | 55.44% | 5.82% | -57.01% |
| 2025 | $701.20M | $-67.90M | 49.77% | -8.78% | -9.68% |